Related Experiment Videos
[Nausea and vomiting during treatment with cytostatics]
1Onkologisk avdeling, Det Norske Radiumhospital, Oslo.
Summary
Severe nausea and vomiting from chemotherapy can halt treatment. This review examines antiemetic drug regimens, recommending optimal strategies to manage chemotherapy-induced nausea and vomiting (CINV) and ensure treatment completion.
Area of Science:
- Oncology
- Pharmacology
- Clinical Medicine
Context:
- Chemotherapy is a cornerstone of cancer treatment.
- Chemotherapy often causes severe side effects, including nausea and vomiting.
- These symptoms can significantly impact patient quality of life and treatment adherence.
Purpose:
- To review current antiemetic drug regimens for managing chemotherapy-induced nausea and vomiting (CINV).
- To evaluate the efficacy and side effect profiles of different antiemetic treatments.
- To provide evidence-based recommendations for optimal antiemetic therapy in cancer patients.
Summary:
- Metoclopramide is a potent antiemetic, historically used in various dosages, sometimes combined with dexamethasone and diazepam.
- The review synthesizes data on various antiemetic strategies.
- Recommendations are provided for effective CINV management.
Impact:
- Improved patient tolerance of chemotherapy.
- Reduced treatment delays or interruptions.
- Enhanced adherence to potentially curative cancer therapies.
- Better quality of life for patients undergoing chemotherapy.